We found that patients with high expression of PAR2 were associated with advanced tumor-node-metastasis (TNM) stage (p = 0.005), and relative high serum AFP level (p = 0.060), but not with other characteristics such as gender, age, etiology, tumor, size, vascular invasion, and pathological stage. The gene discussed is F2RL1; the disease is neoplasm.